Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Express Scripts
Colorcon
Mallinckrodt
Boehringer Ingelheim

Last Updated: December 2, 2022

Carvedilol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for carvedilol and what is the scope of freedom to operate?

Carvedilol is the generic ingredient in four branded drugs marketed by ACI, Aurobindo Pharma, Beximco Usa, Chartwell Molecular, Dr Reddys Labs Ltd, Glenmark Generics, Hikma, Lupin, Mylan, Pliva Hrvatska Doo, Rubicon, Sandoz, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Taro, Teva, Zydus Pharms Usa Inc, Woodward, Impax Labs Inc, and Sun Pharm Industries, and is included in twenty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for carvedilol. Forty-two suppliers are listed for this compound.

Drug Prices for carvedilol

See drug prices for carvedilol

Drug Sales Revenue Trends for carvedilol

See drug sales revenues for carvedilol

Recent Clinical Trials for carvedilol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityN/A
Wonju Severance Christian HospitalPhase 4
Samsung Medical CenterPhase 4

See all carvedilol clinical trials

US Patents and Regulatory Information for carvedilol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva CARVEDILOL carvedilol TABLET;ORAL 076373-001 Sep 5, 2007 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Beximco Usa CARVEDILOL carvedilol TABLET;ORAL 078384-004 Sep 5, 2007 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Sun Pharm Industries CARVEDILOL PHOSPHATE carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 090132-002 Oct 25, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for carvedilol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Woodward COREG carvedilol TABLET;ORAL 020297-002 Sep 14, 1995 See Plans and Pricing See Plans and Pricing
Woodward COREG carvedilol TABLET;ORAL 020297-003 Sep 14, 1995 See Plans and Pricing See Plans and Pricing
Woodward COREG carvedilol TABLET;ORAL 020297-003 Sep 14, 1995 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Harvard Business School
Medtronic
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.